Moleculin Biotech (MBRX) Q1 2025 Annual Earnings
MBRX·Reported May 13, 2025·After market close
Diluted EPS came in at $-17.25 (+65.8% YoY), beat the $-17.75 consensus by $0.50.
Diluted EPS
$-17.25beat by $0.50
Consensus: $-17.75
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about Moleculin Biotech's Q1 2025 earnings report.
Moleculin Biotech (MBRX) reported Q1 2025 earnings on May 13, 2025 after market close.
Moleculin Biotech reported diluted EPS of $-17.25 for Q1 2025.
EPS beat the consensus estimate of $-17.75 by $0.50.
Compared to the same quarter a year prior, diluted EPS grew 65.8% from $-50.50.
You can read the 10-K/A periodic report (0001437749-25-012375) directly on SEC EDGAR. The filing index links above go to sec.gov.